glp-1 and muscle mass loss Weight with medicines does not result in a disproportionate loss of or function in obese mice humans How can people maintain muscle

GLP-1 receptor agonists have been shown to improve diabetes, reduce cardiovascular events, and cause life-changing weight loss

Final rule expected late 2026

4,18 Data suggest that dulaglutide and liraglutide may be associated with higher rates of nausea, vomiting, and constipation compared with semaglutide, whereas pharmacovigilance analyses indicate that semaglutide carries the greatest signal strength for these AEs

Rodents have substantially higher densities of GLP-1 receptors on thyroid C-cells compared to humans, and their thyroid physiology differs markedly from that of humans

Additionally, it significantly reduced the activation of CASP3, a crucial component of apoptotic pathways